Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study

BACKGROUND: The recent interferon-free direct-acting antiviral (DAA) regimens have very good safety and efficacy profiles and are highly recommended for kidney transplant (KT) recipients with chronic hepatitis C (CHC). METHODS: All KT recipients with CHC followed at our hospital and who received the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Gastroenterol
Autori principali: Darema, Maria, Cholongitas, Evangelos, Filiopoulos, Vassilis, Marinaki, Smaragdi, Pavlopoulou, Ioanna D., Tsoubou, Ioanna, Boletis, John N., Papatheodoridis, George V.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hellenic Society of Gastroenterology 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7196623/
https://ncbi.nlm.nih.gov/pubmed/32382232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2020.0481
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi